Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Enity confidentiality form

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

As the respiratory syncytial virus (RSV) season draws to a close on March 31, 2025, we want to remind all healthcare providers of essential considerations regarding administering the RSV immunization, nirsevimab (Beyfortus).   End of RSV season: Continue to administer doses of nirsevimab to eligible children through March 31,...

This presentation for healthcare providers will include updates, guidance, and recommendations from the Pennsylvania Department of Health, including subject matter experts from the Bureau of Epidemiology, the Bureau of Laboratories, and the Bureau of Immunizations. Agenda Update from the Department of Health on the current status of...

Educate your patients about Influenza! According to the Centers for Disease Control and Prevention, influenza levels nationwide are at their highest since the peak of the 2009 swine flu pandemic. Nationally, CDC reports 98 pediatric deaths this season. This season is now classified as a high severity season for...

Our Spring PIC conference is coming up. We hope to see you there.  Questions? Interested in being a panelist? Email angel.brice@phila.gov. ...

PhilaVax Closed to VFC & VFAAR Orders from 3/26 through 4/1 PhilaVax will be temporarily closed to new orders from 12 p.m. on Wednesday, March 26, 2025, until Wednesday, April 2, 2025, while the vaccine prices are updated for 2025. Any orders entered into PhilaVax IIS during this time will be...

MMR vaccination is essential for healthcare professionals, international travelers, and other specific groups. Measles continues to circulate in the United States, with a large outbreak currently growing in Texas. Adults should be up to date on MMR vaccinations with either 1 or 2 doses (depending on risk factors);...

This blog post was written alongside Dr. Mayssa Abuali, a Pediatric Infectious Diseases specialist and the medical director of the Philadelphia Department of Health’s Immunization Program.  Measles continues to circulate in the United States, with a large outbreak growing in Texas. This outbreak has tragically led to...

Update by March 28, 2025 Digital Data Loggers (DDLs) provided by the Philadelphia Department of Public Health (PDPH) use LogTag software to download temperature data. LogTag version 2 is no longer supported and may cause data reporting errors. Therefore, all providers who use PDPH-provided DDLs must update...

VFC/VFAAR Re-enrollment Begins Today! The Philadelphia Vaccines for Children (VFC)/Vaccines for Adults at Risk (VFAAR) annual re-enrollment period is now open! Sites enrolled in VFC and/or VFAAR must submit a re-enrollment form by February 28, 2025 to continue participating in these programs. Follow these 3 steps for a...

Recommend HPV Vaccine Using the Guidance Below The HPV vaccine is approved for ages 9 years through 45 years for all genders. The American Cancer Society and American Academy of Pediatrics (AAP) recommend vaccination starting at age 9. Early vaccination at ages 9-10 has several benefits, including...